Font Size: a A A
Keyword [Unresectable]
Result: 101 - 120 | Page: 6 of 8
101. Evaluation Of Neoadjuvant Therapy In Improving The Therapeutic Effect Of Hepatocellular Carcinoma: A Meta-analysis
102. Efficacy Of Conversion Therapy In Initially Unresectable Pancreatic Cancer
103. Simultaneous Integrated Boost Intensity-modulated Radiation Therapy (SIB-IMRT) Concurrent With Tegafur,Gimeracil And Oteracil Porassium Capsules For Unresectable Locally Advanced Esophageal Carcinoma
104. Impact Of The Different Intervals Between The First And Second Transarterial Chemoembolization On Liver Function In Patients With Unresectable Hepatocellular Carcinoma
105. To Compare The Efficacy And Safety Of BGB-A317 And Sorafenib As First-line Therapy In Patients With Unresectable Hepatocellular Carcinoma
106. Establishment A Prognostic Score Model For Predicting The Prognosis Of Patients With Unresectable Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy
107. Prognostic Model Establishment And Individualized Treatment Strategy Study Of Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer
108. Treatment Of Primary Tumor For Rectal Cancer Patients With Unresectable Liver Metastases
109. Construction And Validation Of Prognostic Models And A Screening Score For Primary Tumor Resection In Unresectable Advanced Colon Cancer
110. Conversion Surgery For Initially Unresectable Stage Ⅲ Non-Small Cell Lung Cancer After Induction Treatment Of Immunochemotherapy:A Multicenter Study
111. Radiotherapy Combined Anti-PD-1 For The Patients With Unresectable Hepatocellular Carcinoma:A Clinical Research
112. Clinical Researches On Prediction And Treatment For Recurrence And Metastasis Of Primary Liver Cancer
113. Clinical Efficacy And Related Biomarker Of TACE Combined With Targeted Immunotherapy For Unresectable Hepatocellular Carcinoma
114. Predicting Response To Transarterial Chemoembolization In Unresectable Hepatocellular Carcinoma Based On PyRadiomics
115. Clinical Practice Of Targeted And Immunotherapy For Hepatocellular Carcinoma And Research On Related Biomarker
116. Efficacy Of Anrotinib Maintenance Therapy After Concurrent Chemoradiotherapy In Unresectable Locally Advanced Non-small Cell Lung Cancer
117. Analysis Of Curative Effect Of Conversion Therapy For Colorectal Cancer With Simultaneous Unresectable Liver Metastasis And Establishment Of Prognosis Model
118. Efficacy Analysis Of Gemcitabine Plus Albumin-bound Paclitaxel Combined With PD-1 Mab In Unresectable Pancreatic Cancer
119. Clinical Study Of Hepatic Arterial Infusion Chemotherapy Combined With Anti-PD-1 Antibody And Lenvatinib In The Treatment Of Unresectable Hepatocellular Carcinoma
120. Cost-utility Analysis Of Atezolizumab Plus Bevacizumab Versus Sorafenib As First-line Therapy In Unresectable Or Metastatic Hepatocellular Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to